What Are Chinese Pharma CEOs Ranting About? (Part 1 of 2)
This article was originally published in PharmAsia News
Executive Summary
Top pharma executives in China get a chance to air their rants during a once-a-year “meet the regulators” session in Beijing, while regulators including the CFDA deputy commissioner share candid views on pertinent industry issues such as the drug approval backlog, pricing, provincial tenders and the essential drug list.